Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR1 | P21554 | 20/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2064119 | 0.93 | CNR1 (1.00) | CNR1 | |
| SCHEMBL2065373 | 0.92 | CNR1 (0.92) | CNR1 | |
| SCHEMBL6123611 | 0.92 | CNR1 (1.00) | CNR1 | |
| SCHEMBL2063738 | 0.90 | CNR1 (1.00) | CNR1 | |
| SCHEMBL2064953 | 0.89 | CNR1 (0.80) | CNR1 | |
| SCHEMBL2063268 | 0.88 | CNR1 (0.86) | CNR1 | |
| SCHEMBL2064184 | 0.88 | CNR1 (0.80) | CNR1 | |
| SCHEMBL2065249 | 0.88 | CNR1 (0.92) | CNR1 | |
| SCHEMBL2064276 | 0.88 | CNR1 (0.89) | CNR1 | |
| SCHEMBL2063405 | 0.87 | CNR1 (0.77) | CNR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2121659-B1 | MODULATORS OF CB1 RECEPTORS | 7TM PHARMA AS (DK) | 2013-05-15 | — | — | EP | disclosed |
| US-8148404-B2 | Modulators of CB1 receptors | 7TM PHARMA A/S (DK) | 2012-04-03 | — | — | US | disclosed |
| US-20100144701-A1 | Modulators of CB1 Receptors | 7TM PHARMA A/S (DK) | 2010-06-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100144701-A1 | Modulators of CB1 Receptors | CNR1, CNR2, GPR6 | CNR1 1/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.